TheProfitWatch

MRK - Merck & Co., Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
95.1 3.06 (3.22%) -0.09 (-0.1%) -0.31 (-0.31%) -0.64 (-0.65%) 0.56 (0.59%) 2.68 (2.81%) -0.09 (-0.1%) 0.63 (0.67%)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
1.76
Diluted EPS:
1.76
Basic P/E:
55.7727
Diluted P/E:
55.7727
RSI(14) 1m:
45.52
VWAP:
98.24
RVol:

Events

Period Kind Movement Occurred At

Related News